166 related articles for article (PubMed ID: 13695799)
1. [Experiments on the pathogenesis of Wilson's disease. 4. The action of alpha-lipoic acid on the metabolism of copper and proteins in cases of hepatolenticular degeneration (recent observations)].
da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
Gaz Med Port; 1960; 13():706-22. PubMed ID: 13695799
[No Abstract] [Full Text] [Related]
2. [On the pathogenesis and therapy of Wilson's disease. The effect of alpha-lipoic acid (preliminary communication)].
da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
Arzneimittelforschung; 1960 May; 10():333-9. PubMed ID: 13695801
[No Abstract] [Full Text] [Related]
3. [On the biochemical pathology of Wilson's disease. New observations on the action of alpha-liponic acid].
da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
Arzneimittelforschung; 1961 May; 11():438-44. PubMed ID: 13695800
[No Abstract] [Full Text] [Related]
4. [Current views on the pathogenesis of Wilson's disease].
Szeliga J
Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542
[No Abstract] [Full Text] [Related]
5. [Utilization of copper in the organism and its role in the pathogenesis of Wilson's disease].
Marceau N
Union Med Can; 1974 Dec; 103(12):2104-6. PubMed ID: 4619238
[No Abstract] [Full Text] [Related]
6. [A study on the pathogenesis of hepatolenticular degeneration using an in vitro model].
Chen XZ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):133-5, 190. PubMed ID: 2591264
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic significance of alpha-lipoic acid. V. Comparative action of alpha-lipoic acid, vitamin B 12 and cocarboxylase on metabolism of copper and iron and on aminoacidurias. (Further observations)].
da COSTA S; da SILVA J; CORREIA JA; MALDONADO FE
Arq Patol; 1963 Apr; 35():91-7. PubMed ID: 14023281
[No Abstract] [Full Text] [Related]
8. Copper metabolism in Wilson's disease.
WINTROBE MM; CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; BEAN WB
Trans Assoc Am Physicians; 1954; 67():232-41. PubMed ID: 13216832
[No Abstract] [Full Text] [Related]
9. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
10. [3 cases of Wilson's disease in adults, with special reference to copper metabolism screening with 64Cu].
Yoshida K; Noguchi S; Suzuki M; Nishitani H; Fukase M
Rinsho Shinkeigaku; 1976 Jul; 16(7):529-35. PubMed ID: 986923
[No Abstract] [Full Text] [Related]
11. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
Chromý K
Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
[No Abstract] [Full Text] [Related]
12. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
13. [Recent acquisitions in the study of Wilson's disease].
Sternlieb I
Rev Med Chir Mal Foie; 1965 Sep; 40(4):199-204. PubMed ID: 5851771
[No Abstract] [Full Text] [Related]
14. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
15. [Metabolism in Wilson's disease. Whole body counting of 64Cu].
Terao T; Nakao K; Ogihara K; Mozai T; Nagai T
Igaku To Seibutsugaku; 1967 Jun; 74(6):304-8. PubMed ID: 5624888
[No Abstract] [Full Text] [Related]
16. Biochemical reactions of copper within neural mitochondria, with consideration of the role of the metal in the pathogenesis of Wilson's disease.
VOGEL FS; KEMPER L
Lab Invest; 1963 Feb; 12():171-9. PubMed ID: 13997625
[No Abstract] [Full Text] [Related]
17. Hepatolenticular degeneration (Wilson's disease): observations in 7 cases and review of the literature.
Tapia HR; Cavazos N
South Med J; 1970 Jan; 63(1):82-9. PubMed ID: 5415807
[No Abstract] [Full Text] [Related]
18. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
19. Serum selenium concentration in patients with Wilson's disease.
Swiatkowska-Stodulska R; Dejneka W; Jabłońska-Kaszewska I; Lukasiak J; Kiszkis H; Wiśniewski P; Lubińska M; Sworczak K
Hepatogastroenterology; 2007 Sep; 54(78):1788-90. PubMed ID: 18019719
[TBL] [Abstract][Full Text] [Related]
20. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
